Data are limited, however. In mice, ingesting exercise mimetics appeared to improve depressive-like behaviors, and the ...

About one in eight U.S. adults are currently taking a GLP-1 drug such as Ozempic, Wegovy, or Zepbound to treat diabetes, ...

This article examines how exercise-induced exerkines prevent disease, as well as promote metabolic, cardiovascular, immune, ...

Researchers from The University of Osaka find that chronic liver congestion is linked to severe liver diseases through a specific signaling pathway in liver sinusoidal endothelial cells - key cells ...

Researchers from The University of Osaka have developed a mouse model for achondroplasia. The model identified the importance ...

The long-term stasis of blood in the liver, known as chronic liver congestion, can lead to a range of diseases, some of which ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

About one in eight U.S. adults are currently taking a GLP-1 drug such as Ozempic, Wegovy, or Zepbound to treat diabetes, obesity, or other conditions ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company developing therapies for life-threatening immune and thrombotic disorders, today provided additional perspectives on ...

A neuroscientist and assistant professor at the University of Alberta presented his research on the neural mechanisms of ...

Explore the benefits of the Precision GLP-1 agonist, a new therapy that improves glycaemic control and reduces side effects.

A wave of recent neuroscience research has identified specific molecular and cellular mechanisms through which alcohol disrupts signaling between brain cells, offering a sharper picture of how ...